Cell-Based Therapeutics: The Next Pillar of Medicine

See allHide authors and affiliations

Science Translational Medicine  03 Apr 2013:
Vol. 5, Issue 179, pp. 179ps7
DOI: 10.1126/scitranslmed.3005568


Two decades ago, the pharmaceutical industry—long dominated by small-molecule drugs—was revolutionized by the the advent of biologics. Today, biomedicine sits on the cusp of a new revolution: the use of microbial and human cells as versatile therapeutic engines. Here, we discuss the promise of this “third pillar” of therapeutics in the context of current scientific, regulatory, economic, and perceptual challenges. History suggests that the advent of cellular medicines will require the development of a foundational cellular engineering science that provides a systematic framework for safely and predictably altering and regulating cellular behaviors.

View Full Text

Stay Connected to Science Translational Medicine